SND1 divergent transcript (SND1-DT)

"SND1 divergent transcript" (SND1-DT) is not a canonical protein target or established therapeutic molecule. By convention, 'divergent transcript' refers to a long non-coding RNA (lncRNA) transcribed in the opposite direction from the SND1 locus. Current research widely recognizes *SND1* as a multifaceted gene encoding Staphylococcal nuclease and Tudor domain containing 1—an evolutionarily conserved protein involved in gene regulation, RNA splicing, editing and stability, and post-transcriptional gene silencing, notably with disease roles in cancer[2][3][5]. The "SND1-DT" itself does not appear in reference databases or key literature as a distinct target, receptor, or enzyme and is not supported as a validated therapeutic target. If information about the functional role, disease association, or drug interaction of "SND1-DT" is needed, further experimental research or more precise nomenclature is needed.